{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:43:10Z","timestamp":1759970590858,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07497-5","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:36:43Z","timestamp":1759919803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging nationwide epidemiological big data for diabetes modeling and disease surveillance: an innovative approach for advancing public health policy in developing countries"],"prefix":"10.1186","volume":"18","author":[{"given":"Hadi","family":"Hayati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razieh Askari","family":"Zahabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"7497_CR1","unstructured":"World Health Organization. Introduction to drug utilization research. Geneva: World Health Organization;2003. https:\/\/apps.who.int\/iris\/handle\/10665\/42627"},{"key":"7497_CR2","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 9th ed. Brussels: International Diabetes Federation;2019. https:\/\/diabetesatlas.org"},{"issue":"3","key":"7497_CR3","doi-asserted-by":"publisher","DOI":"10.5812\/iranjradiol-123781","volume":"19","author":"H Hayati","year":"2022","unstructured":"Hayati H. Comparison of the unit cost of diagnostic imaging services before and during the COVID-19 pandemic using the activity-based costing (ABC) method. Iran J Radiol. 2022;19(3):e123781. https:\/\/doi.org\/10.5812\/iranjradiol-123781.","journal-title":"Iran J Radiol"},{"key":"7497_CR4","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. https:\/\/diabetesatlas.org."},{"issue":"10","key":"7497_CR5","doi-asserted-by":"publisher","first-page":"e005859","DOI":"10.1136\/bmjopen-2014-005859","volume":"4","author":"A Sarayani","year":"2014","unstructured":"Sarayani A, Rashidian A, Gholami K. Policy options for rational use of antidiabetic medications: a population-based study in Iran. BMJ Open. 2014;4(10):e005859. https:\/\/doi.org\/10.1136\/bmjopen-2014-005859.","journal-title":"BMJ Open"},{"issue":"6","key":"7497_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.aogh.2015.12.015","volume":"81","author":"S Noshad","year":"2015","unstructured":"Noshad S, Saadat M, Gheibi S, Mobasseri M, Khamseh ME, Azimi-Nezhad M, et al. Diabetes mellitus and its complications in North-West iran: A review. Ann Glob Health. 2015;81(6):839\u201350. https:\/\/doi.org\/10.1016\/j.aogh.2015.12.015.","journal-title":"Ann Glob Health"},{"key":"7497_CR7","unstructured":"World Health Organization. WHO collaborating centre for drug statistics methodology. ATC\/DDD Index 2013. Geneva: WHO; 2013.\u00a0https:\/\/www.whocc.no\/atc_ddd_index\/"},{"issue":"5","key":"7497_CR8","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2337\/dc13-2289","volume":"37","author":"C Hampp","year":"2014","unstructured":"Hampp C, Borders-Hemphill V, Moeny DG, Wysowski DK. Use of antidiabetic drugs in the U.S. 2003\u20132012. Diabetes Care. 2014;37(5):1367\u201374. https:\/\/doi.org\/10.2337\/dc13-2289.","journal-title":"Diabetes Care"},{"issue":"7","key":"7497_CR9","doi-asserted-by":"publisher","first-page":"e0178764","DOI":"10.1371\/journal.pone.0178764","volume":"12","author":"A \u015aliwczy\u0144ski","year":"2017","unstructured":"\u015aliwczy\u0144ski A, Brzozowska M, Ja\u017cd\u017cewska E, Roma\u0144czyk M, Karnafel W. Nationwide database analysis of antidiabetic drug utilization in Poland 2012\u20132015. PLoS ONE. 2017;12(7):e0178764. https:\/\/doi.org\/10.1371\/journal.pone.0178764.","journal-title":"PLoS ONE"},{"key":"7497_CR10","first-page":"225","volume":"21","author":"ME Khamseh","year":"2022","unstructured":"Khamseh ME, et al. Ten-year trend in anti-diabetic drug utilization in iran: A population-based cohort study. J Diabetes Metab Disord. 2022;21:225\u201332.","journal-title":"J Diabetes Metab Disord"},{"issue":"9","key":"7497_CR11","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1007\/s00125-006-0299-5","volume":"49","author":"A Melander","year":"2006","unstructured":"Melander A, Stenstr\u00f6m P, Ahren B. Drug utilization in diabetes care: A Swedish register-based study. Diabetologia. 2006;49(9):2024\u20139. https:\/\/doi.org\/10.1007\/s00125-006-0299-5.","journal-title":"Diabetologia"},{"issue":"3","key":"7497_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pcd.2017.03.003","volume":"11","author":"R L\u00f3pez-Sep\u00falveda","year":"2017","unstructured":"L\u00f3pez-Sep\u00falveda R, Galv\u00e1n-Banqueri M, L\u00f3pez-Mu\u00f1oz F, Mart\u00ednez-Mart\u00ednez F, Lomas-Campos MM, S\u00e1nchez F, et al. Antidiabetic drug utilization: analysis and forecasting (2004\u20132018) in a Spanish population. Prim Care Diabetes. 2017;11(3):254\u201364. https:\/\/doi.org\/10.1016\/j.pcd.2017.03.003.","journal-title":"Prim Care Diabetes"},{"issue":"Suppl 2","key":"7497_CR13","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.2337\/dc09-S318","volume":"32","author":"SG Swinnen","year":"2009","unstructured":"Swinnen SG, Hoekstra JB, DeVries JH. Insulin therapy for type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):S253\u20139. https:\/\/doi.org\/10.2337\/dc09-S318.","journal-title":"Diabetes Care"},{"issue":"8","key":"7497_CR14","first-page":"1013","volume":"5","author":"H Ravaghi","year":"2014","unstructured":"Ravaghi H, Sajadi HS, Ebrahimipour H, Jamshidi HR. Policy analysis of health system strengthening in Iran, a comparison with selected countries. Int J Prev Med. 2014;5(8):1013\u201322.","journal-title":"Int J Prev Med"},{"key":"7497_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2251-6581-13-17","volume":"13","author":"H Karimi Moonaghi","year":"2014","unstructured":"Karimi Moonaghi H, Emami Zeydi A, Mirhosseini H, Sharifnia SH, Taghadosi M. Attitude and perceptions of Iranian nurses toward evidence-based practice. J Diabetes Metab Disord. 2014;13:17. https:\/\/doi.org\/10.1186\/2251-6581-13-17.","journal-title":"J Diabetes Metab Disord"},{"key":"7497_CR16","unstructured":"World Health Organization. Noncommunicable Diseases (NCD) Country Profiles 2018: Iran. Cairo: WHO\/EMRO;2018. https:\/\/www.who.int\/nmh\/countries\/irn_en.pdf"},{"key":"7497_CR17","volume-title":"Koda-Kimble and young\u2019s applied therapeutics: the clinical use of drugs","year":"2012","unstructured":"Koda-Kimble MA, Young LY, editors. Koda-Kimble and young\u2019s applied therapeutics: the clinical use of drugs. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.","edition":"10"},{"key":"7497_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12902-021-00790-x","volume":"21","author":"S Hariri","year":"2021","unstructured":"Hariri S, Rahimi Z, Hashemi-Madani N, Mard SA, Hashemi F, Mohammadi Z, et al. Prevalence and determinants of diabetes and prediabetes in Southwestern Iran: the Khuzestan comprehensive health study (KCHS). BMC Endocr Disord. 2021;21:150. https:\/\/doi.org\/10.1186\/s12902-021-00790-x.","journal-title":"BMC Endocr Disord"},{"key":"7497_CR19","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s13300-021-01152-5","volume":"12","author":"ME Khamseh","year":"2021","unstructured":"Khamseh ME, Sepanlou SG, Hashemi-Madani N, Joukar F, Mehrparvar AH, Faramarzi E, et al. Nationwide prevalence of diabetes and prediabetes and associated risk factors among Iranian adults: analysis of data from PERSIAN cohort study. Diabetes Ther. 2021;12:2921\u201338. https:\/\/doi.org\/10.1007\/s13300-021-01152-5.","journal-title":"Diabetes Ther"},{"issue":"3","key":"7497_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.pcd.2021.04.002","volume":"15","author":"S Barati","year":"2021","unstructured":"Barati S, Sadeghipour P, Ghaemmaghami Z, Mohebbi B, Baay M, Alemzadeh-Ansari MJ, et al. Warning signals of elevated prediabetes prevalence in the modern Iranian urban population. Prim Care Diabetes. 2021;15(3):472\u20139. https:\/\/doi.org\/10.1016\/j.pcd.2021.04.002.","journal-title":"Prim Care Diabetes"},{"issue":"3","key":"7497_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pcd.2017.01.003","volume":"11","author":"R L\u00f3pez-Sep\u00falveda","year":"2017","unstructured":"L\u00f3pez-Sep\u00falveda R, Lirola M\u00c1G, Garc\u00eda EE, Mart\u00ednez JMJ, Sances SM, Ord\u00f3\u00f1ez SA, et al. Antidiabetic medications use trends in an Andalusian region from 2001 to 2014. Prim Care Diabetes. 2017;11(3):254\u201364. https:\/\/doi.org\/10.1016\/j.pcd.2017.01.003.","journal-title":"Prim Care Diabetes"},{"issue":"2","key":"7497_CR22","first-page":"64","volume":"2","author":"SE Hosseini","year":"2014","unstructured":"Hosseini SE, Tavakoli F, Karami M. Medicinal plants in the treatment of diabetes mellitus. J Clin Excellence. 2014;2(2):64\u201389.","journal-title":"J Clin Excellence"},{"key":"7497_CR23","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels: IDF;2021. https:\/\/www.diabetesatlas.org\/"},{"key":"7497_CR24","unstructured":"Iranian students\u2019 news agency. Who is Compulsory Health Insurance Free for? [Updated: 2 November 2019. https:\/\/www.isna.ir\/news\/98081106063\/. Accessed 10 May 2021."},{"issue":"5","key":"7497_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.18502\/ijph.v52i5.12725","volume":"52","author":"A Shojaee","year":"2023","unstructured":"Shojaee A, Akbari Sari A, Farzadfar F, Davari M, Daroudi R, Shajari Pour Mousavi SM. Utilization trend of parenteral antidiabetic drugs in type 2 diabetes mellitus in iran: 2011\u20132019. Iran J Public Health. 2023;52(5):1071\u201380. https:\/\/doi.org\/10.18502\/ijph.v52i5.12725.","journal-title":"Iran J Public Health"},{"issue":"Suppl 2","key":"7497_CR26","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1016\/j.jfma.2019.06.001","volume":"118","author":"C-H Chu","year":"2019","unstructured":"Chu C-H, Hsu C-C, Lin S-Y, et al. Trends in antidiabetic medical treatment from 2005 to 2014 in Taiwan. J Formos Med Assoc. 2019;118(Suppl 2):S74\u201382. https:\/\/doi.org\/10.1016\/j.jfma.2019.06.001.","journal-title":"J Formos Med Assoc"},{"key":"7497_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/ijpvm.ijpvm_290_22","volume":"14","author":"H Hayati","year":"2023","unstructured":"Hayati H, Piramoon M. Preventive risk assessment of medication in intensive wards. Int J Prev Med. 2023;14:117. https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_290_22.","journal-title":"Int J Prev Med"},{"key":"7497_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12875-025-02831-z","volume":"26","author":"H Hosseini","year":"2025","unstructured":"Hosseini H, Rassouli M, Hayati H, Heydari H. The effect of community-based palliative supportive care integrated with primary health care (PHC) on the outcomes of terminally ill cancer patients. BMC Prim Care. 2025;26:139. https:\/\/doi.org\/10.1186\/s12875-025-02831-z.","journal-title":"BMC Prim Care"},{"key":"7497_CR29","doi-asserted-by":"publisher","first-page":"110147","DOI":"10.1016\/j.diabres.2022.110147","volume":"198","author":"ML Mendes","year":"2023","unstructured":"Mendes ML, Costa JCL, Ribeiro AQ, Hernandes AP, Sim\u00f5es AC, Nascimento RCRM. Utilization trends of antidiabetic medicines in brazil, 2013\u20132021: A nationwide analysis. Diabetes Res Clin Pract. 2023;198:110147. https:\/\/doi.org\/10.1016\/j.diabres.2022.110147.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"7497_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.pcd.2022.01.006","volume":"16","author":"M Ramesh","year":"2022","unstructured":"Ramesh M, Parthasarathi G, Mothi SN, Dorairajan LN, Mothi SN, Londhe S, et al. Prescribing patterns of antidiabetic medicines in india: A cross-sectional study in diverse regional settings. Prim Care Diabetes. 2022;16(4):567\u201374. https:\/\/doi.org\/10.1016\/j.pcd.2022.01.006.","journal-title":"Prim Care Diabetes"},{"issue":"6","key":"7497_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7196\/SAMJ.2021.v111i6.15426","volume":"111","author":"N Tadross","year":"2021","unstructured":"Tadross N, Dave JA, van Heerden J, Crowther NJ, Levitt NS. Update on type 2 diabetes mellitus management and disparities in treatment access in South Africa. S Afr Med J. 2021;111(6):505\u201310. https:\/\/doi.org\/10.7196\/SAMJ.2021.v111i6.15426.","journal-title":"S Afr Med J"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07497-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:36:48Z","timestamp":1759919808000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07497-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7497"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07497-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The quantitative component of this study was based exclusively on anonymized secondary data from routine health information systems and therefore did not require ethics approval under national regulations. The qualitative component, involving semi-structured interviews with human participants, was reviewed and approved by the Medical Ethics Committee of Ahvaz Jundishapur University of Medical Sciences (Approval code: IR.AJUMS.REC.1401.043). Written informed consent to participate was obtained from all interview participants prior to data collection. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and relevant national guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not relevant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"423"}}